Thursday, August 17, 2017 5:05:43 PM
Meanwhile, you have the possibility of further ANDA approvals. We know they should be coming but that is not a guarantee. Nor can it be guaranteed that the ones that would be most helpful will be the ones that get approved the fastest.
Some sort of partnership on Regbatin is also a possibility but i would not bet too heavily on that.
A new CFO could give a little hope but it is hard for me to see them attracting someone who would make us all say "how did they ever convince him to come aboard?".
The obvious nasty thing which could happen would be a deeply discounted equity offering as they need money to keep pushing forward.
We will not hear about Focalin and Seroquel sales until early October but my guess is these are more likely to disappoint than excite.
Clearly, if there is a PR that offers hope on the Rexista front, some of what has been lost in the stock price will be gained back. If the FDA grants them tentative approval on 9/25 for IV, then a lot will be gained back (and the data says theys hould despite the loony ADCOM vote).
PODRAS is still the big winner here but they need to complete human trials and we don't know where the company is at with that. If they are good, the stock should jump again in a big way but it could take some time before it is treated seriously due to management shortcomings and the related lack fo institutional research coverage.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM